selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['selinexor', 'bridge bio']
bcbn feed: karyopharm to present data from phase 1 study of selinexor in patients with treatment-na ve myelofibrosis at aacr and to host investor webcast on april 18th: updated safety and efficacy data ... #boston #biotech 
Boston Cambridge Biotech Networks: Building a community and providing news and events for the local life science industry. For jobs follow @bcbnjobs